DOSEF (Doseology Sciences) Other Current Payables: $0.00 Mil (As of Mar. 2026)


DOSEF Doseology Sciences Inc DOSEF
32 GF Score
Price $0.11
GF Value $0.15
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Doseology Sciences Other Current Payables?

Doseology Sciences DOSEF -16.16% 32 Other Current Payables is $0.00 Mil as of Mar. 2026. GuruFocus rates DOSEF with a GF Score™ of 32/100 and a GF Value™ of $0.15 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Doseology Sciences's Other Current Payables for the quarter that ended in Mar. 2026 was $0.00 Mil.

Doseology Sciences Other Current Payables Related Terms

Doseology Sciences Other Current Payables Historical Data

* Premium members only.

The historical data trend for Doseology Sciences's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Doseology Sciences Other Current Payables Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
Get a 7-Day Free Trial 0.28 0.01 0.00 0.00 0.00

Doseology Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DOSEF
32GF Score
Doseology Sciences Inc DOSEF
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Doseology Sciences Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Doseology Sciences (DOSEF) has a Other Current Payables of $0.00 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Doseology Sciences and its competitors.
Is Doseology Sciences' Other Current Payables too high?
Doseology Sciences' current Other Current Payables is $0.00 Mil. Overall, Doseology Sciences has a GF Score™ of 32/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doseology Sciences' Other Current Payables compare to VRTX and REGN?
Doseology Sciences' Other Current Payables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Doseology Sciences and its competitors. Doseology Sciences's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doseology Sciences stock overvalued right now?
Based on GuruFocus' analysis, Doseology Sciences (DOSEF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.15, compared to a current price of $0.11 — trading 25.3% below its estimated fair value. The current Other Current Payables is $0.00 Mil. Doseology Sciences' overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Doseology Sciences (DOSEF), the current Other Current Payables is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doseology Sciences (DOSEF) Overvalued in 2026?

Based on GuruFocus' analysis, Doseology Sciences stock appears to be undervalued. The current stock price of $0.11 is trading 25.3% below its estimated GF Value™ of $0.15. GuruFocus considers Doseology Sciences to be Modestly Undervalued.

Key valuation signals for DOSEF:

  • Other Current Payables: $0.00 Mil
  • GF Value™: $0.15 vs. price of $0.11 (25.3% below fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the DOSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Doseology Sciences Business Description

Other Exchanges MOOD:Canada
Address 9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
32GF Score

Get the complete analysis for DOSEF

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price
$0.15
GF Value